BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence - Drugs.com MedNews

Links shared publicly online about this topic.

  • 18
    total visits

BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence - Drugs.com MedNews

drugs.com —

Promising data allows for the potential initiation of pivotal bioequivalence study by year-end BioDelivery Sciences International, Inc. (Nasdaq BDSI) announced

View full resource at drugs.com

Tags: Drug, Science, Opiate

  • Share

Most Recently Shared on September 6, 2011 at 12:06 pm By:

Drugs_Devices Drugs and Devices OW

BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opi... http://t.co/wIzk0qq #drug

9 months ago...

Reply

Retweet

Favorite

Advertisement